Chemical Compound

Nilotinib

CAS Registry Number 641571-10-0

Back to search Request a Quote

Primary Record

Nilotinib

In stock: 4,871 g
Purity: 98.2 %
CAS: 641571-10-0

Compound Identifiers & Properties

CAS: 641571-10-0
PubChem CID: 644241
SMILES: CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
Canonical SMILES: Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1

Names & Synonyms

Nilotinib
Tasigna
641571-10-0
nilotinibum
Danziten
AMN107
Nilotinib free base
Nilotinib/
Nilotinib;
Nilotinib?
AMN 107
AMN-107
Nilotinib-d6
Nilotinib [USAN]
Nilotinib D6
Tasigna (Novartis)
Nilotinib (AMN-107)
Nilotinib(AMN-107)
Nilotinib (Standard)
3gp0
NILOTINIB [INN]
RefChem:58968
Gallic Acid Cetyl Ester
NILOTINIB [MI]
C28H22F3N7O
MFCD09833716
Nilotinib (INN/USAN)
Nilotinib (USAN/INN)
AMN 107 Base
NILOTINIB [HSDB]
NILOTINIB [VANDF]
Nilotinib [USAN:INN:BAN]
D00STL
D06GGT
NILOTINIB [MART.]
Nilotinib, AMN107, Tasigna
AC1LD8U3
NILOTINIB [USP-RS]
NILOTINIB [WHO-DD]
SCHEMBL7901
CHEMBL255863
HHZIURLSWUIHRB-UHFFFAOYSA-N
DTXSID5042663
NILOTINIB [EMA EPAR]
cc-353
CHEBI:52172
HSDB 7842
MLS003915611
MLS006010160
Nilotinib & its intermediates
NSC-747599
Nilotinib - Bio-X trade mark
Nilotinib hydrochloride hydrate
Nilotinib hydrochloride monohydrate
GTPL5697
orb1308331
UNII-F41401512X
Tasigna, AMN-107, Nilotinib
DTXCID3022663
SCHEMBL29366964
SCHEMBL29580067
CTK8B3214
641571-10-0 (free base)
L01XE08
QCR-112
SYN1057
NSC747599
BCPP000149
GLXC-90226
HMS3244A13
HMS3244A14
HMS3244B13
HMS3295A23
HMS3654M07
HMS3748E11
HMS5079M05
AOB87115
BCP01367
EX-A8380
KS-00000GT9
TAC35617
ZINC6716957
ABP000478
AC-647
ANW-41982
BDBM50237710
C28-H22-F3-N7-O
CID644241
EBC-11364
FC0027
HY-10159R
MSK159953
NSC800804
RS0102
s1033
F41401512X
4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide
AKOS005063561
ACN-038315
AN-5308
BCP9000989
CCG-264784
CS-0102
CS-O-01983
DB04868
FM10831
NSC 747599
NSC-800804
RTX-011143
SB17315
SDCCGSBI-0634418.P004
Nilotinib (BCR-ABL inhibitor 2nd gen)
NCGC00183285-01
NCGC00183285-03
NCGC00183285-04
NCGC00183285-09
NCGC00183285-15
4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}benzamide
AK-59889
AS-16214
BC224537
BN164654
BR-59889
EN002707
HY-10159
SC-19640
SMR002544680
SY024415
EC 700-544-5
4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide
AB0007991
ST2413627
TL8004531
A8232
AM20090651
FT-0654026
l-1-yl)-3-(trifluoromethyl)phenyl]benzamide
NS00000665
SW218083-2
V0705
EC-000.2344
J2.203.300J
A10644
D08953
N-8207
S-6060
49312-EP2270008A1
49312-EP2292617A1
49312-EP2305667A2
49312-EP2311840A1
78680-EP2305667A2
AB01273978-01
AB01273978-02
AB01273978_03
EN300-7381984
139316-EP2270008A1
139316-EP2292617A1
571N100
A834657
F079266
P111010
Q412327
SR-01000931150
4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide
4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide
I01-1225
SR-01000931150-2
BRD-K81528515-001-04-7
BRD-K81528515-001-13-8
4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)benzamide
Z1741976994
B0084-074229
4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-{(4-(pyridin-3-yl)pyrimidin-2-yl)amino}benzamide
4-Methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-
MCL-1-specific antisense oligonucleotide + nilotinib (AMN107)
1268356-17-7
4-Methyl-3-(4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]benzamide
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]benzamide
4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)-phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide
4-Methyl-N-[3-(4-methyl-1-imidazolyl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridyl)-2-pyrimidyl]amino]benzamide
4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-benzamide
4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzamide
4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]benzamide
Benzamide, 4-methyl-N-((3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-(4-(3-pyridinyl)-2-pyrimidinyl)amino)-
N-(3-(3-(1H-Imidazolyl)propoxy)phenyl)-4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)benzamide
NIL
Nilotinib,AMN107,Tasigna;4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazo
1215678-43-5
1353151-22-0
2,3,6-trideuterio-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-5-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-4-(trideuteriomethyl)benzamide
4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-N-[3-[4-(trideuteriomethyl)imidazol-1-yl]-5-(trifluoromethyl)phenyl]benzamide
4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2
4-Methyl-N-[3-(4-methyl-1H-imidazole-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridyl)-2-pyrimidinyl]amino]benzamide
4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4 -pyridin-3-ylpyrimidin-2-yl)amino]benzamide
4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino] benzamide
4-Methyl-N-[3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl]-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzamide
benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride, hydrate
Benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-(4-(3-pyridinyl)-2-pyrimidinyl)amino)-
Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]- (9CI)
Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-(9CI)
Benzamide,4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-
N-[3-(4-Methyl-1H-imidazole-1-yl)-5-(trifluoromethyl)phenyl]-4-methyl-3-[4-(3-pyridyl)pyrimidine-2-ylamino]benzamide
N-[3-(Trifluoromethyl)-5-(4-methyl-1H-imidazole-1-yl)phenyl]-4-methyl-3-[4-(3-pyridyl)-2-pyrimidinylamino]benzamide
n-[3-[3-(1h-imidazolyl)propoxy]phenyl]-4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzamide